JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.1793rr5
The Journal of Cell Biology, Vol. 179, No. 3, 363-
The Rockefeller University Press, 0021-9525 $30.00
© Sedwick
This Article
Right arrow Full Text (PDF, 1065K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sedwick, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sedwick, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Roundup

Cholesterol and Alzheimer's


Alzheimer's disease (AD) presents in early- and late-onset forms that share the same neuronal pathology but have different genetic causes. A new study by Qiang Liu, Guojun Bu (Washington University, St. Louis, MO), and colleagues now suggests that both AD forms are linked to a cholesterol pathway.

Cholesterol was already linked to late-onset AD. The best-known risk factor for this disease is a specific form of apolipoprotein E (apoE), which delivers lipids such as cholesterol to neurons. But early-onset AD stems from mutations in genes encoding amyloid precursor protein (APP) or its cleaving enzymes, which result in the accumulation of disease-associated Aß amyloids. How these disparate pathways both lead to AD was not known.

In addition to Aß, APP cleavage also produces the APP intracellular domain (AICD) peptide. Liu et al. now show that AICD blocks the apoE pathway, thereby lowering cholesterol levels in the brain. AICD blocked the lipid's import into neurons by reducing the expression of the apoE receptor, LRP1.

In AD, APP processing gone awry might cause AICD to accumulate, thus depriving neurons of cholesterol. Both early and late forms of AD may therefore stem at least in part from faulty, cholesterol-deprived neurons.

"We now have a better idea of APP's function in the brain," says Bu. "It could be linked to disease through both Aß-dependent and -independent mechanisms." Formula

Reference:

Liu, Q., et al. 2007. Neuron. 56:66–78.[CrossRef][Medline]



Caitlin Sedwick

csedwick{at}gmail.com


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 1065K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sedwick, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sedwick, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents